NPO — EnPro Industries, Inc.
NYSE
Q4 2025 Earnings Call Summary
February 18, 2026
Enpro Q4 2025 Earnings Call Summary
1. Key Financial Results and Metrics
- Sales: Q4 sales increased 14.3% to $295.4 million, with full-year sales up 9% to $1.14 billion.
- Organic Sales Growth: Organic sales rose approximately 10% in Q4, driven by aerospace, food and biopharma sectors, and contributions from recent acquisitions.
- Adjusted EBITDA: Q4 adjusted EBITDA was $69.4 million, up 19.2%, with an adjusted EBITDA margin of 23.5%, reflecting a 100 basis point increase.
- Earnings Per Share: Adjusted diluted EPS rose nearly 27% to $1.99.
- Free Cash Flow: Generated over $150 million in free cash flow for 2025, up 18% from 2024.
2. Strategic Updates and Business Highlights
- Growth Strategy: Enpro is executing its Enpro 3.0 strategy, focusing on organic growth and strategic acquisitions, allocating two-thirds of capital expenditures toward growth initiatives.
- Acquisitions: Completed acquisitions of AlpHa Measurement Solutions and Overlook Industries for $280 million, which are expected to enhance growth in the Sealing Technologies segment.
- Performance by Segment:
- Sealing Technologies: Sales increased nearly 15% in Q4, with an adjusted segment EBITDA margin of 32.8%.
- Advanced Surface Technologies (AST): Sales rose 13.4% in Q4, driven by precision cleaning solutions, although operating expenses increased due to growth investments.
3. Forward Guidance and Outlook
- 2026 Sales Growth: Expected total sales growth of 8% to 12%, including approximately $60 million from recent acquisitions.
- Adjusted EBITDA: Projected to be between $305 million and $320 million.
- Earnings Per Share: Expected adjusted diluted EPS in the range of $8.50 to $9.20.
- Capital Expenditures: Anticipated at approximately $50 million, or around 4% of sales, focused on growth opportunities.
4. Bad News, Challenges, or Points of Concern
- Commercial Vehicle OEM Demand: Expected to remain flat to slightly down, which may impact overall growth.
- Nuclear Market Volatility: Continued choppiness in nuclear sales, particularly in Europe, could affect performance.
- Increased Operating Expenses: Higher corporate expenses, particularly medical costs and short-term incentives, could pressure margins.
- Semiconductor Market Recovery: While there are signs of recovery, the first half of 2026 is expected to show moderate growth, with stronger performance anticipated in the second half.
5. Notable Q&A Insights
- AST Margins: Management expects significant margin improvement in the second half of 2026, driven by increased demand and the realization of growth investments.
- Sealing Technologies Outlook: The segment is expected to outperform the market with mid-single-digit organic growth, supported by strong demand in aerospace and food and biopharma.
- M&A Strategy: Enpro remains disciplined in pursuing strategic acquisitions, focusing on assets that align with their growth strategy and provide complementary capabilities.
- Order Patterns: Management noted an acceleration in order bookings, particularly in AST, with expectations for a robust second half of 2026.
This summary encapsulates Enpro's performance and outlook as discussed in the Q4 2025 earnings call, highlighting both achievements and challenges ahead.
